Literature DB >> 18817471

Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Michelle Longmire1, Peter L Choyke, Hisataka Kobayashi.   

Abstract

Nanoparticles possess enormous potential as diagnostic imaging agents and hold promise for the development of multimodality agents with both imaging and therapeutic capabilities. Yet, some of the most promising nanoparticles demonstrate prolonged tissue retention and contain heavy metals. This presents serious concerns for toxicity. The creation of nanoparticles with optimal clearance characteristics will minimize toxicity risks by reducing the duration of exposure to these agents. Given that many nanoparticles possess easily modifiable surface and interior chemistry, if nanoparticle characteristics associated with optimal clearance from the body were well established, it would be feasible to design and create agents with more favorable clearance properties. This article presents a thorough discussion of the physiologic aspects of nanoparticle clearance, focusing on renal mechanisms, and provides an overview of current research investigating clearance of specific types of nanoparticles and nano-sized macromolecules, including dendrimers, quantum dots, liposomes and carbon, gold and silica-based nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817471      PMCID: PMC3407669          DOI: 10.2217/17435889.3.5.703

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  72 in total

1.  Therapeutic antibody fragments with prolonged in vivo half-lives.

Authors:  A P Chapman; P Antoniw; M Spitali; S West; S Stephens; D J King
Journal:  Nat Biotechnol       Date:  1999-08       Impact factor: 54.908

2.  In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.

Authors:  D W Cagle; S J Kennel; S Mirzadeh; J M Alford; L J Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Plasma and renal clearance of iohexol--a study on the reproducibility of a method for the glomerular filtration rate.

Authors:  A Arvidsson; A Hedman
Journal:  Scand J Clin Lab Invest       Date:  1990-11       Impact factor: 1.713

4.  Magnetic resonance angiography with gadomer-17. An animal study original investigation.

Authors:  Q Dong; D R Hurst; H J Weinmann; T L Chenevert; F J Londy; M R Prince
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

5.  Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.

Authors:  Yuda Zong; Xinghe Wang; K Craig Goodrich; Aaron M Mohs; Dennis L Parker; Zheng-Rong Lu
Journal:  Magn Reson Med       Date:  2005-04       Impact factor: 4.668

6.  Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats.

Authors:  H Harashima; T M Huong; T Ishida; Y Manabe; H Matsuo; H Kiwada
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

7.  Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure.

Authors:  Hisataka Kobayashi; Sang-Kyung Jo; Satomi Kawamoto; Hideo Yasuda; Xuzhen Hu; Michael V Knopp; Martin W Brechbiel; Peter L Choyke; Robert A Star
Journal:  J Magn Reson Imaging       Date:  2004-09       Impact factor: 4.813

8.  Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.

Authors:  K Funato; R Yoda; H Kiwada
Journal:  Biochim Biophys Acta       Date:  1992-01-31

9.  Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent.

Authors:  Philippe Bourrinet; Howard H Bengele; Bruno Bonnemain; Anne Dencausse; Jean-Marc Idee; Paula M Jacobs; Jerome M Lewis
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

Review 10.  A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors.

Authors:  Ron Hardman
Journal:  Environ Health Perspect       Date:  2006-02       Impact factor: 9.031

View more
  454 in total

1.  Optimization of liposomal indocyanine green for imaging of the urinary pathways and a proof of concept in a pig model.

Authors:  Yael Friedman-Levi; Liraz Larush; Michele Diana; Francesco Marchegiani; Jacques Marescaux; Noam Goder; Guy Lahat; Joseph Klausner; Sara Eyal; Shlomo Magdassi; Eran Nizri
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

2.  Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.

Authors:  Forrest M Kievit; Freddy Y Wang; Chen Fang; Hyejung Mok; Kui Wang; John R Silber; Richard G Ellenbogen; Miqin Zhang
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

Review 3.  Biologically optimized nanosized molecules and particles: more than just size.

Authors:  Michelle R Longmire; Mikako Ogawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2011-05-11       Impact factor: 4.774

4.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

Review 5.  The use of nanoparticulates to treat breast cancer.

Authors:  Xiaomeng Tang; Welley S Loc; Cheng Dong; Gail L Matters; Peter J Butler; Mark Kester; Craig Meyers; Yixing Jiang; James H Adair
Journal:  Nanomedicine (Lond)       Date:  2017-09-04       Impact factor: 5.307

6.  Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.

Authors:  Jonathan O Martinez; Brandon S Brown; Nicoletta Quattrocchi; Michael Evangelopoulos; Mauro Ferrari; Ennio Tasciotti
Journal:  Chin Sci Bull       Date:  2012-11-01

7.  Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T1 contrast for heating.

Authors:  Jinjin Zhang; Hattie L Ring; Katie R Hurley; Qi Shao; Cathy S Carlson; Djaudat Idiyatullin; Navid Manuchehrabadi; P Jack Hoopes; Christy L Haynes; John C Bischof; Michael Garwood
Journal:  Magn Reson Med       Date:  2016-09-25       Impact factor: 4.668

Review 8.  Advances in gadolinium-based MRI contrast agent designs for monitoring biological processes in vivo.

Authors:  Jacques Lux; A Dean Sherry
Journal:  Curr Opin Chem Biol       Date:  2018-05-09       Impact factor: 8.822

Review 9.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

10.  Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.

Authors:  Ching-Hui Huang; Kido Nwe; Ajlan Al Zaki; Martin W Brechbiel; Andrew Tsourkas
Journal:  ACS Nano       Date:  2012-10-29       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.